Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1978 Dec;40(12):1397–1401. doi: 10.1136/hrt.40.12.1397

Effects of prostaglandin E1 on pulmonary circulation in patients with pulmonary hypertension.

J Szczeklik, J S Dubiel, M Mysik, Z Pyzik, R Krol, T Horzela
PMCID: PMC483585  PMID: 737098

Abstract

The effects of prostaglandin E1 on pulmonary circulation and left ventricular performance have been studied in 20 patients with mitral valve disease and pulmonary hypertension. Prostaglandin E1 was administered intravenously over a period of 30 minutes. The dose used was 0.01 microgram/kg per min during the first 15 minutes and 0.02 microgram/kg per min subsequently. The first dose led only to an insignificant fall in left ventricular end-diastolic pressure. Infusion of prostaglandin E1 in a dose of 0.02 microgram/kg per min resulted in a significant fall in the pulmonary arterial pressure (P less than 0.001), total pulmonary resistance (P less than 0.001), left ventricular end-diastolic pressure (P less than 0.001), and aortic pressure (P less than 0.01), and an increase in the pulmonary blood volume (P less than 0.01), cardiac index (P less than 0.01), and heart rate (P less than 0.05). No significant differences were noted in stroke volume index or left ventricular dP/dt at 50 mmHg after prostaglandin E1. These results indicate that exogenously administered prostaglandin E1 causes active vasodilatation of the pulmonary vascular bed and has no inotropic action on the cardiac muscle.

Full text

PDF
1399

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERGSTROM S., DUNER H., von EULER U., PERNOW B., SJOVALL J. Observations on the effects of infusion of prostaglandin E in man. Acta Physiol Scand. 1959 Mar 31;45:145–151. doi: 10.1111/j.1748-1716.1959.tb01686.x. [DOI] [PubMed] [Google Scholar]
  2. Bergofsky E. H. Mechanisms underlying vasomotor regulation of regional pulmonary blood flow in normal and disease states. Am J Med. 1974 Sep;57(3):378–394. doi: 10.1016/0002-9343(74)90133-8. [DOI] [PubMed] [Google Scholar]
  3. Bergström S., Carlson L. A., Ekelund L. G., Orö L. Cardiovascular and metabolic response to infusions of prostaglandin E1 and to simultaneous infusions of noradrenaline and prostaglandin E1 in man. Prostaglandin and related factors 35. Acta Physiol Scand. 1965 Aug;64(4):332–339. doi: 10.1111/j.1748-1716.1965.tb04187.x. [DOI] [PubMed] [Google Scholar]
  4. Carlson L. A., Ekelund L. G., Orö L. Circulatory and respiratory effects of different doses of prostaglandin E1 in man. Acta Physiol Scand. 1969 Jan-Feb;75(1):161–169. doi: 10.1111/j.1748-1716.1969.tb04368.x. [DOI] [PubMed] [Google Scholar]
  5. DONATO L., GIUNTINI C., LEWIS M. L., DURAND J., ROCHESTER D. F., HARVEY R. M., COURNAND A. Quantitative radiocardiography. I. Theoretical considerations. Circulation. 1962 Aug;26:174–182. doi: 10.1161/01.cir.26.2.174. [DOI] [PubMed] [Google Scholar]
  6. Hauge A., Lunde P. K., Waaler B. A. Effects of prostaglandin E1 and adrenaline on the pulmonary vascular resistance (PVR) in isolated rabbit lungs. Life Sci. 1967 Apr 1;6(7):673–680. doi: 10.1016/0024-3205(67)90122-1. [DOI] [PubMed] [Google Scholar]
  7. Hyman A. L. The active responses of pulmonary veins in intact dogs to prostaglandins F2 alpha and E1. J Pharmacol Exp Ther. 1969 Feb;165(2):267–273. [PubMed] [Google Scholar]
  8. Joiner P. D., Kadowitz P. J., Hughes J. P., Hyman A. L. Actions of prostaglandins E1 and F2alpha on isolated intrapulmonary vascular smooth muscle. Proc Soc Exp Biol Med. 1975 Nov;150(2):414–421. doi: 10.3181/00379727-150-39047. [DOI] [PubMed] [Google Scholar]
  9. Kadowitz P. J., Joiner P. D., Hyman A. L., George W. J. Influence of prostaglandins E1 and F2alpha on pulmonary vascular resistance, isolated lobar vessels and cyclic nucleotide levels. J Pharmacol Exp Ther. 1975 Mar;192(3):677–687. [PubMed] [Google Scholar]
  10. Koss M. C., Gray J. W., Davison M., Nakano J. Cardiovascular actions of prostaglandins E1 and F2 alpha in the cat. Eur J Pharmacol. 1973 Nov;24(2):151–157. doi: 10.1016/0014-2999(73)90065-4. [DOI] [PubMed] [Google Scholar]
  11. Mason D. T., Braunwald E., Covell J. W., Sonnenblick E. H., Ross J., Jr Assessment of cardiac contractility. The relation between the rate of pressure rise and ventricular pressure during isovolumic systole. Circulation. 1971 Jul;44(1):47–58. doi: 10.1161/01.cir.44.1.47. [DOI] [PubMed] [Google Scholar]
  12. OAKLEY C., GLICK G., LURIA M. N., SCHREINER B. F., Jr, YU P. N. Some regulatory mechanisms of the human pulmonary vascular bed. Circulation. 1962 Nov;26:917–930. doi: 10.1161/01.cir.26.5.917. [DOI] [PubMed] [Google Scholar]
  13. Schreiner B. F., Jr, Murphy C. W., James D. H., Yu P. N. Effects of isoproterenol on the pulmonary blood volume in patients with valvular heart disease and primary myocardial disease. Circulation. 1968 Feb;37(2):220–231. doi: 10.1161/01.cir.37.2.220. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES